PALEXIA Retard 50 mg tabletten met verlengde afgifte
Approved small_molecule active
Quick answer
PALEXIA Retard 50 mg tabletten met verlengde afgifte for chronic postoperative pain is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- chronic postoperative pain
- Phase
- Approved
- Modality
- small_molecule
- Status
- active